Clinical Discussion Series
![]() | First-line Treatment of HL: Differential Treatment Strategies in Newly Diagnosed Patients with Early- versus Advanced-Stage Disease CME, CPE Andrew M. Evens, DO, MSc, FACP | |
Release Date: April 27, 2016 Expiration Date: April 27, 2017 | ||
Dr. Andrew Evens will address the critical differences in therapeutic strategies for patients who are diagnosed with early stage HL versus those who are diagnosed at an advanced stage. Through a practical review of the newest regimens and strategies, Dr. Evens will discuss the latest evidence supporting the differential use of each as first-line therapy for the newly diagnosed HL patient. To download the accompanying e-Transcript for reference purposes only click here. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Takeda Oncology | ||
View Only, CE ExpiredView Only, No Credit | ||